Table 1.
Normoxia | Hypoxia | Recovery | |
---|---|---|---|
pHa | |||
Saline | 7.43 ± 0.02 | 7.49 ± 0.02 | 7.46 ± 0.02 |
V1 antagonist | 7.46 ± 0.02 | 7.50 ± 0.02 | 7.49 ± 0.02 |
Phentolamine | 7.44 ± 0.01 | 7.46 ± 0.05 | — |
Pa,CO2(mmHg) | |||
Saline | 36.8 ± 1.1 | 32.8 ± 0.8* | 34.1 ± 1.6 |
V1 antagonist | 36.4 ± 0.6 | 31.9 ± 1.1* | 33.7 ± 1.5 |
Phentolamine | 33.9 ± 3.4 | 34.7 ± 3.1 | — |
Pa,O2(mmHg) | |||
Saline | 89.8 ± 1.7 | 34.5 ± 1.7* | 86.0 ± 3.4 |
V1 antagonist | 88.8 ± 3.1* | 32.4 ± 2.5* | 81.4 ± 3.9 |
Phentolamine | 85.3 ± 5.6 | 39.0 ± 5.9* | — |
%satHb | |||
Saline | 93.5 ± 1.6 | 74.6 ± 2.3* | 93.5 ± 1.5 |
V1 antagonist | 94.5 ± 1.2 | 71.3 ± 3.8* | 94.3 ± 1.6 |
Phentolamine | 93.2 ± 2.1 | 68.7 ± 13.5* | — |
[Hb](g dl−1) | |||
Saline | 9.8 ± 0.3 | 11.0 ± 0.4 | 10.2 ± 0.3 |
V1 antagonist | 9.9 ± 0.4 | 11.7 ± 0.5 | 10.2 ± 0.4 |
Phentolamine | 9.8 ± 0.5 | 10.9 ± 0.4 | — |
O2 capacity (vol. % O2) | |||
Saline | 13.1 ± 0.4 | 14.7 ± 0.5 | 13.6 ± 0.4 |
V1 antagonist | 13.3 ± 0.6 | 15.6 ± 0.6* | 13.6 ± 0.5 |
Phentolamine | 13.1 ± 0.7 | 14.7 ± 0.5 | — |
O2 content (vol. % O2) | |||
Saline | 12.3 ± 0.5 | 11.0 ± 0.6 | 12.8 ± 0.5 |
V1 antagonist | 12.6 ± 0.6 | 11.1 ± 0.8 | 12.9 ± 0.7 |
Phentolamine | 12.3 ± 0.9 | 10.1 ± 2.2 | — |
Base excess (mequiv l−1) | |||
Saline | −0.6 ± 1.1 | 1.7 ± 1.3 | 0.9 ± 1.4 |
V1 antagonist | 1.9 ± 1.2 | 1.3 ± 0.9 | 2.3 ± 0.6 |
Phentolamine | −1.1 ± 1.7 | 1.0 ± 2.5 | — |
Values are means ± s.e.m. of all values obtained during each of the experimental hours when the fetuses were infused with saline, V1 antagonist, or phentolamine. pHa, arterial pH; Pa,CO2, arterial CO2 pressure; Pa,O2, arterial O2 pressure; %satHb, percentage saturation of Hb. Significant differences (P < 0.05)
hypoxia or recovery vs. normoxia (ANOVA + Student-Newman-Keuls test).